FOX CHASE CANCER CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1904-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.foxchase.org
Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.
- Conditions
- First Posted Date
- 2024-10-22
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 100
- Registration Number
- NCT06652347
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
MRD Guided De-intensification of Bendamustine/Rituximab for Indolent Non-Hodgkin Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2024-08-16
- Last Posted Date
- 2024-10-10
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT06557330
Testing Gene PilotLX With Latinx Cancer Patients
- First Posted Date
- 2024-06-27
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 232
- Registration Number
- NCT06476938
- Locations
- 🇺🇸
MD Anderson Cancer Center at Cooper, Camden, New Jersey, United States
🇺🇸Herbert Irving Comprehensive Cancer Center, New York, New York, United States
🇺🇸Temple University, Philadelphia, Pennsylvania, United States
HPV Self-sampling for Underscreened Latinas
- Conditions
- Interventions
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-10-15
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 108
- Registration Number
- NCT06439706
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Genomic Risk in Retroperitoneal Sarcoma
- Conditions
- Interventions
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-05-31
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT06436846
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Reducing Urban Cervical Cancer Disparities
- Conditions
- Interventions
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 546
- Registration Number
- NCT06416150
- Locations
- 🇺🇸
Rutgers, The State University of New Jersey, New Brunswick, New Jersey, United States
🇺🇸Thomas Jefferson University, Philadelphia, Pennsylvania, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)
- Conditions
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-08-23
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 92
- Registration Number
- NCT06396533
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
mychoiceTM Implementation With Medical Oncology Patients
- First Posted Date
- 2024-01-24
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT06222242
- Locations
- 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition
- First Posted Date
- 2024-01-23
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Fox Chase Cancer Center
- Target Recruit Count
- 24
- Registration Number
- NCT06218628
- Locations
- 🇺🇸
Fox Chase Cancer Center - Philadelphia, Philadelphia, Pennsylvania, United States
A Pilot Study of Circulating Tumor DNA Adaptive Risk Maintenance Approach for Bladder Cancer (CARMA)
- Conditions
- Interventions
- First Posted Date
- 2023-09-22
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Fox Chase Cancer Center
- Registration Number
- NCT06050954